Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Kratochvílová, , Iva,
DOB: 17-SEP-1964 (Age: 61)
Gender: female
ID: 4380-389488-0 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 23-MAR-2025

Problem list

Condition Onset Date Status
Chronic kidney disease stage 2 22-May-2022 active
Chronic kidney disease stage 1 28-Feb-2021 active
Metabolic syndrome X 19-Jan-2014 active
Sepsis 06-Mar-2011 active
Anemia 09-Jan-2011 active
Prediabetes 27-Dec-2009 active
Proteinuria due to type 2 diabetes mellitus 01-Sep-2002 active
Microalbuminuria due to type 2 diabetes mellitus 04-Aug-2002 active
Osteoarthritis of hip 05-Apr-1998 active
Chronic sinusitis 17-May-1992 active
Disorder of kidney due to diabetes mellitus 08-Jul-1990 active
Essential hypertension 31-Jul-1983 active

Medication list

Medication Since Form Dosage Reason
insulin isophane human 70 UNT/ML / insulin regular human 30 UNT/ML Injectable Suspension [Humulin] 2025-03-23 - 10 units subcutaneously before breakfast and dinner Prediabetes
Hydrochlorothiazide 25 mg oral tablet 2025-03-23 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet 2025-03-23 - 1 tablet (300 mg/5 mg) by mouth every 4 to 6 hours as needed for pain -
Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin] 2025-03-23 - 1 tablet (10 mg) every 12 hours -
24 HR tacrolimus 1 MG Extended Release Oral Tablet 2025-03-23 - 1 tablet (1 mg) by mouth once daily History of renal transplant (situation)

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 02-Feb-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 21-Aug-2022
SARS-CoV-2 mRNA vaccine 23-May-2021

Procedure History list

Procedure Date Reason
Depression screening 15-Oct-2023 -
Medication reconciliation 15-Oct-2023 -
Assessment of health and social care needs 15-Oct-2023 -
Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) 15-Oct-2023 -
Assessment of substance use 15-Oct-2023 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 15-Oct-2023 -
Transplantation of kidney regime 09-May-2016 History of renal transplant (situation)
Transplant of kidney 07-May-2016 Awaiting transplantation of kidney (situation)
Pretransplant evaluation of kidney recipient 07-May-2016 Awaiting transplantation of kidney (situation)

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Care plan 07-May-2016 -
Therapy 03-Apr-2014 -
Dialysis care plan 12-Jan-2011 -
Diabetes self management plan 27-Dec-2009 Prediabetes
  • Maintain hemoglobin A1c below 6.5% to reduce risk of diabetes progression.
  • Achieve and maintain at least 5% weight loss from baseline to improve glycemic control.
  • Maintain blood pressure below 130/80 mmHg to reduce cardiovascular risk.
  • Engage in at least 150 minutes of moderate-intensity physical activity per week.
Lifestyle education regarding hypertension 31-Jul-1983 Essential hypertension (disorder)
  • Achieve and maintain systolic blood pressure within recommended target range through lifestyle modifications.
  • Achieve and maintain diastolic blood pressure within recommended target range through lifestyle modifications.
  • Reduce daily sodium intake to recommended levels as part of hypertension management.
  • Achieve and maintain a healthy body weight to support blood pressure control.
  • Engage in at least 150 minutes of moderate-intensity physical activity per week to support blood pressure control.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-03-23 2025-02-02
Body Height 170.9 cm 170.9 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} 2 {score}
Body Weight 87.8 kg 87.5 kg
Body mass index (BMI) [Ratio] 30.1 kg/m2 30 kg/m2
Diastolic Blood Pressure 98 mm[Hg] 105 mm[Hg]
Systolic Blood Pressure 115 mm[Hg] 125 mm[Hg]
Heart rate 78 /min 74 /min
Respiratory rate 15 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 23-MAR-2025 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 89.6 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 7.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 1.9 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 10.1 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Serum or Plasma 138.8 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 3.8 3.5 - 5 mmol/L
Chloride [Moles/volume] in Serum or Plasma 106.4 H 98 - 106 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 21.3 L 22 - 29 mmol/L
Appearance of Urine Cloudy urine
Odor of Urine Urine smell ammoniacal
Clarity of Urine Translucent
Color of Urine Brown color
Glucose [Mass/volume] in Urine by Test strip 1.3 H 0 - 0.8 mg/dL
Glucose [Presence] in Urine by Test strip ++
Bilirubin.total [Mass/volume] in Urine by Test strip 0.9 0 - 1 mg/dL
Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine
Ketones [Mass/volume] in Urine by Test strip 2.0 0 - 4 mg/dL
Ketones [Presence] in Urine by Test strip Urine ketone test = +
Specific gravity of Urine by Test strip 1.0 L 1.005 - 1.03 {nominal}
pH of Urine by Test strip 6.1 4.5 - 7 pH
Protein [Mass/volume] in Urine by Test strip 318.1 H 0 - 145 mg/dL
Protein [Presence] in Urine by Test strip Urine protein test = ++
Nitrite [Presence] in Urine by Test strip Urine nitrite negative
Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative
Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative
Hemoglobin A1c/Hemoglobin.total in Blood 3.4 L 4 - 6 %
Glucose [Mass/volume] in Blood 89.6 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 7.4 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 1.8 H 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 10.1 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 138.8 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.8 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.4 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.3 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 181.3 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 110.0 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 111.0 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 48.4 L 50 - 100 mg/dL

Device Use

Device Date (since)
Blood glucose meter (physical object) 27-Dec-2009
Manual wheelchair (physical object) 05-Apr-1998
Wheelchair accessory (physical object) 05-Apr-1998
Home nebulizer (physical object) 17-May-1992